The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1267 articles
Structure Therapeutics announced impressive Phase 2 results for its daily obesity pill, with patients losing about 16% of their body weight compared to placebo after 44 weeks. This positions the company to challenge leaders like Eli Lilly and Novo Nordisk in the race for effective oral GLP-1 therapies. Discover the details and implications for obesity treatment.
Zydus Lifesciences and Lupin are teaming up to bring Semaglutide injection to India, positioning it as a rival to Ozempic for type 2 diabetes and chronic weight management. Marketed by Zydus with a user-friendly reusable pen, this GLP-1 therapy offers new options for adults with poor glycemic control or obesity-related conditions. Here's what patients need to know about this launch.
Stopping Ozempic can lead to full weight regain in about 1.7 years, plus reversal of cardiovascular and metabolic benefits, warns a major BMJ review. Nearly 50% of users discontinue within a year due to side effects and high costs. Doctors urge consulting before quitting to protect your health gains.
Melissa McCarthy turned heads at the 2026 Oscars in a stunning gown, but her noticeably slimmer face reignited Ozempic rumors. Side-by-side pics with her 2012 Oscars appearance make the change crystal clear. Onstage, she even poked fun at the speculation during a Bridesmaids reunion.
Novo Nordisk, maker of Ozempic and Wegovy, has launched a three-year research partnership to test weight-loss GLP-1 drugs on adolescents in Pacific Island nations, beginning in Fiji. Announced amid a Danish royal visit, this move addresses the obesity 'ticking bomb' threatening kids' lifespans. CEO Mike Doustdar urges bolder action on prevention and access.
Revolutionary GLP-1 medications like Ozempic are helping millions shed pounds quickly, but a new study shows significant muscle loss is a downside. Experts warn that up to 40% of weight lost can be lean tissue, especially with rapid drops. Here's how to protect your muscle while benefiting from these drugs.
Layla Taylor, star of The Secret Lives of Mormon Wives, has stepped away from GLP-1 medications after using them as an unhealthy crutch for her lifelong eating disorder. Ahead of season 4, she opens up about hidden side effects like aching joints, falling hair, and constant fatigue that signaled her body was breaking down. Her story underscores the importance of monitoring GLP-1 use, especially with pre-existing conditions.
Two women were rushed to the hospital and intubated after receiving peptide injections at a Las Vegas anti-aging festival. Nevada regulators fined providers $35,000 for unlicensed practice and wholesaling. This incident highlights the dangers of unregulated peptides promoted for anti-aging.
The surge in GLP-1 drug use among 12% of Americans is upending the food industry, with sauce and spice makers like Bachan's and Tapatio attracting high-value deals. As these medications dull taste buds and spur lean protein consumption, condiment companies are seeing explosive growth. Fast-food giants face billions in losses while flavor enhancers thrive.
